Ayahuasca / Yage
An Amazonian Sacrament, a Discovery of Indigenous Chemistry, and a Sovereignty Question
Evidence grade 2 of 5, Thin. Read how the Atlas grades evidence.
Graded grade 2. Legitimate clinical research exists, including Brazilian studies of ayahuasca for depression, addiction, and PTSD, and study quality is improving, but the controlled evidence base is still small and the ceremonial context is difficult to separate from the pharmacology in the traditional model. We grade the clinical signal honestly as preliminary while taking the traditional therapeutic framework seriously on its own terms.
Reference only. Not medical advice.
What can go wrong
Ayahuasca is physically demanding and not risk-free. Intense vomiting (the purge) is expected, and there are real dangers from interactions between the brew's monoamine oxidase inhibitors and certain medications (notably some antidepressants) and foods, as well as cardiovascular strain and acute psychological distress. The unregulated retreat circuit has documented cases of harm, including deaths, often tied to poor screening or unqualified facilitators. It is contraindicated for people with cardiovascular disease, psychotic disorders, or on interacting medications.
This is something to take to a clinician. The Atlas can tell you what is known about ayahuasca / yage in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.
Ayahuasca sits at the intersection of medicine, spirituality, and law that defines this category, and it leads with Indigenous Amazonian knowledge. The brew unites the Banisteriopsis caapi vine with a DMT-containing plant, and the crucial fact is that DMT is not orally active alone: Amazonian chemists discovered, centuries before Western pharmacology could explain it, that the vine's monoamine oxidase inhibitors unlock it. Clinical research, much of it Brazilian because US Schedule I status pushed the work abroad, finds improving but still preliminary evidence for depression, addiction, and trauma, an honest grade 2. The harder content is the sovereignty dispute: Indigenous communities and many scholars hold that the ceremony, healer, songs, and preparation are inseparable from the medicine, and that Western extraction and commercialization is appropriation that can harm source peoples and deplete the plants. The brew is also physically risky, with dangerous interactions and an unregulated retreat circuit that has caused documented harm.
A brew whose two-plant pharmacology was worked out by Indigenous Amazonian chemists centuries before Western science understood it, now caught between clinical research and a real question about extracting it from its culture.
How it is supposed to work
Proposed and partly characterized: the DMT in the brew acts on serotonin 5-HT2A receptors to produce intense, time-limited altered states, while the vine's monoamine oxidase inhibition both enables oral activity and adds its own pharmacology. Researchers study effects on mood, default-mode network activity, and emotional processing. Traditional understanding frames the mechanism in terms of spirit, purging, and the ceremonial container, a framing its practitioners consider essential rather than metaphorical.
What people get wrong
Often saidAyahuasca is just DMT you can drink.
ActuallyDMT alone is not orally active. Indigenous chemists combined it with a vine supplying monoamine oxidase inhibitors, a sophisticated discovery, and traditional practitioners hold that the ceremony, not the molecule alone, is the medicine.
Often saidA retreat is a safe, regulated medical treatment.
ActuallyThe global retreat circuit is largely unregulated, with documented harms and deaths tied to poor screening and unqualified facilitators, and serious drug and food interaction risks.
Who profits, and who pushes back
Indigenous Amazonian healers
Hold that the ceremony, songs, and preparation are inseparable from any healing the brew brings.
Brazilian clinical researchers
Report antidepressant and anti-addiction signals in small controlled and observational studies.
Sovereignty scholars
Argue Western commercialization is extractive and can harm source communities and the plants.
Toxicologists
Warn of dangerous interactions with antidepressants and foods and of harms in unregulated retreats.
Where the research comes from
Most of the published research on this comes from one place. 97% of it is from Amazon basin (origin). Findings that no unrelated group has reproduced are weaker than the study count makes them look.
| Place | Share of published research |
|---|---|
| Amazon basin (origin) | 97% |
| Brazil | 88% |
| Global retreat circuit | 70% |
| United States (RFRA churches) | 64% |
How we got here
Ayahuasca is Amazonian and Indigenous. It comes from the rainforest cultures of the Amazon basin, among them Quechua-speaking peoples and the Shipibo-Conibo, Shuar, and many others, with archaeological evidence of use dated to around 1000 CE at sites such as Inca Huasi and oral traditions pointing far earlier. The brew combines the Banisteriopsis caapi vine with a DMT-containing plant, and here the lineage holds a remarkable fact: DMT is not orally active on its own, and the vine supplies the monoamine oxidase inhibitors that make it active when drunk. That two-plant combination was discovered and refined by Indigenous Amazonian knowledge long before Western pharmacology could explain why it works.
Amazonian peoples have used ayahuasca ceremonially for at least a millennium and likely far longer. Western prohibition of DMT after 1970 pushed research to Brazil and other jurisdictions, while syncretic churches won religious exemptions in the US and Canada through the 2000s. The 2010s global retreat boom brought both wider access and documented harms, sharpening the sovereignty debate.
- ~1000 CE and earlierAmazonian ceremonial use; archaeology at Inca Huasi
- 1970US DMT Schedule I listing pushes research abroad
- 2006Supreme Court upholds Uniao do Vegetal religious use
- 2009Santo Daime exemption (9th Circuit)
- 2010s-2020sGlobal retreat boom; sovereignty and safety debates intensify
How it is understood
In its source cultures ayahuasca is taken in ceremony led by an experienced healer, with songs (icaros), dietary and behavioral preparation, and a communal container that traditional practitioners regard as inseparable from any healing it brings. It has also spread into syncretic Brazilian churches and a global retreat circuit, settings that vary enormously in safety and cultural grounding.
Where scholars disagree
Indigenous Amazonian communities hold that the brew, the healer, the songs, the preparation, and the community form one inseparable practice, and many regard Western extraction and commercialization as harmful appropriation that can exploit source communities and deplete the plants. The library names this position rather than treating the brew as a free-floating compound.
Alongside the usual evidence questions, ayahuasca carries a genuine cultural-sovereignty dispute. Clinical researchers, particularly in Brazil, study it for depression, addiction, and trauma and find improving but still limited evidence. Indigenous communities and many scholars argue that extracting the brew from its ceremonial context, the healer, the songs, the preparation, the community, may remove what makes it therapeutic, and that Western commercialization of an Indigenous sacrament is an extractive appropriation that can harm source communities and deplete the plants. Both the clinical interest and the sovereignty concern are legitimate and in tension.
Clinical researchers (e.g. Brazilian groups)
Ayahuasca shows promise for depression, addiction, and trauma worth studying rigorously.
What it rests onSmall controlled and observational studies reporting antidepressant and anti-addiction signals.
Indigenous communities and sovereignty scholars
The ceremony is inseparable from the medicine, and extraction and commercialization are harmful appropriation.
What it rests onTraditional knowledge holders' testimony, reports of exploitation and plant depletion in the retreat economy.
This disagreement is live. It has not settled.
At a glance
- Origin
- Amazon basin; use to ~1000 CE and earlier
- Pharmacology
- DMT plus MAOI vine, an Indigenous discovery
- US status
- DMT Schedule I; specific RFRA church exemptions
- Best research base
- Brazil
What this entry does not yet cover
What follows is unfinished work on our side, not a finding about Ayahuasca / Yage. A short entry is not a safe entry.
- Cost and market. We have not documented what it sells for or who sells it.
- Supply chain. We have not mapped where it is made.
- Who uses it. We have not documented the user groups.
- What could change. No forward-looking summary yet.
- How it compares. We have not set it against the alternatives.
- Children and teenagers. We have not checked what is known about younger people.
- What people take it for. We have not catalogued the claims made for it.
Sources
No sources recorded for this entry yet. Nothing on this page can be checked against a citation until that changes, so treat it as a summary awaiting its evidence.